Skip to main content
. 2022 Mar 4;11(5):1412. doi: 10.3390/jcm11051412

Figure 1.

Figure 1

Estimated symptom severity scores of respiratory and non-respiratory symptoms according to the usage of regdanvimab using a linear mixed-effect model. HD = hospitalization day.